Alkermes Investigational Site

Dallas, Texas 75390

1 studies enrolling now · 19 studies all time

What they study most

Alcohol Use Disorder, Major Depressive Disorder, Multiple Sclerosis, Narcolepsy Type 1, Refractory Major Depressive Disorder, Relapsing Remitting Multiple Sclerosis, Schizophrenia

Studies at this site

• A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304) — Recruiting now
• A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1 — Completed
• A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder — Completed
• A Study of ALKS 3831 in Adults With Schizophrenia — Completed
• A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia — Completed
• A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD) — Stopped early
• A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD) — Completed
• A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2 — Completed
• A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study) — Completed
• A Long-Term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia — Completed
• A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-3 Study — Completed
• A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD) — Completed
• A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia — Completed
• A Long-Term Safety Study of ALKS 5461 — Completed
• A Study of Aripiprazole Lauroxil (Also Known as ARISTADA TM) in Subjects With Schizophrenia — Completed
• A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070) — Completed
• An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia — Completed
• A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study) — Completed
• An Extension of a Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070) — Completed